Heparin Bridging with Warfarin Initiation
When initiating warfarin therapy, start warfarin and therapeutic-dose heparin (or LMWH) concomitantly on day 1, overlap for 4-5 days, and discontinue heparin only after the INR reaches therapeutic range (≥2.0) for two consecutive days. 1
Protocol for Warfarin Initiation with Heparin Bridge
Immediate Initiation (Day 1)
- Start both agents simultaneously: Begin warfarin and full-dose heparin on the same day when treating acute thromboembolism 1, 2
- Early warfarin initiation (within 48 hours of heparin start) is safer, less expensive, and equally effective compared to delayed initiation 2
- Warfarin's anticoagulant effect is delayed, making heparin essential for immediate anticoagulation 1
Heparin Dosing Options
Unfractionated Heparin (UFH):
- IV bolus: 70-100 units/kg, followed by continuous infusion at 15-25 units/kg/hr 3
- Target aPTT: 1.5-2.0 times control (not the older 1.5-2.5 range) 3
- Preferred in severe renal insufficiency or dialysis-dependent patients 4
Low-Molecular-Weight Heparin (LMWH):
- Therapeutic dose: enoxaparin 1 mg/kg subcutaneously every 12 hours or dalteparin 100 IU/kg every 12 hours 4
- More commonly used than UFH for bridging 4
- Can be administered on outpatient basis 5
Overlap Duration
- Continue full-dose heparin for 4-5 days minimum 1
- Do not discontinue heparin until warfarin produces therapeutic INR 1
- INR must be ≥2.0 for two consecutive days before stopping heparin 6
INR Monitoring During Overlap
Critical timing considerations when drawing PT/INR while on both agents 1:
- At least 5 hours after last IV heparin bolus
- At least 4 hours after stopping continuous IV heparin infusion
- At least 24 hours after last subcutaneous heparin injection
This timing is essential because heparin can artificially elevate PT/INR results, leading to premature heparin discontinuation.
Warfarin Dosing
- Initial dose: 10 mg daily for 3 days, then titrate to maintain PT 1.2-1.5 times control 2
- Target INR varies by indication but typically 2.0-3.0 for most indications 5
Critical Pitfalls to Avoid
Premature Heparin Discontinuation
The most common error is stopping heparin too early. The INR can rise from warfarin's effect on Factor VII (short half-life) before adequate suppression of Factors II and X occurs, creating a false sense of anticoagulation while the patient remains prothrombotic 1.
Bleeding Risk with Bridging
Important caveat: While bridging is standard for warfarin initiation in acute thromboembolism, recent evidence shows bridging at warfarin initiation in non-valvular atrial fibrillation increases major bleeding (0.9% vs 0.3%) without reducing stroke risk 7. This suggests bridging should be reserved for:
- Acute venous thromboembolism treatment
- High thrombotic risk conditions (mechanical heart valves, recent thrombosis)
- NOT routine atrial fibrillation anticoagulation initiation 7
Monitoring Considerations
- Warfarin may increase aPTT even without heparin present 1
- Severe aPTT elevation (>50 seconds) with therapeutic INR indicates increased postoperative hemorrhage risk 1
- During initial overlap, heparin's interference with INR is minimal clinically 1
Context-Specific Modifications
Perioperative Setting (Different from Initiation)
The perioperative bridging protocol differs substantially from initiation bridging 4, 5:
- Stop warfarin 4-5 days preoperatively
- Bridge with therapeutic LMWH, stopping 24 hours before surgery
- Resume postoperatively at 12-24 hours when hemostasis adequate
- This is distinct from the initiation protocol described above
Renal Impairment
Switch from LMWH to IV UFH in severe renal insufficiency (CrCl <30 mL/min) or dialysis patients, as LMWH accumulates renally 4.
The evidence strongly supports simultaneous initiation with mandatory 4-5 day overlap until stable therapeutic anticoagulation is achieved, but clinicians must distinguish between initiation bridging (for acute thrombosis) versus perioperative bridging (different protocols and risk-benefit profiles).